Patent search ap:("TAKEDA PHARMACEUTICAL COMPANY LIMITED") AND inv:"Tomoya Yukawa" Page 1

1.

发明申请
HETEROCYCLIC COMPOUND 审中-公开
Title translation: 杂环化合物

公开(公告)号：US20170050974A1

公开(公告)日：2017-02-23

申请号：US14902309

申请日：2014-07-02

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Satoshi Yamamoto , Junya Shirai , Hiroyuki Watanabe , Shoji Fukumoto , Tsuneo Oda , Hidekazu Tokuhara , Yoshihide Tomata , Naoki Ishii , Michiko Tawada , Mitsunori Kono , Atsuko Ochida , Takashi Imada , Yoshiyuki Fukase , Tomoya Yukawa

IPC: C07D491/056 , C07D471/04

CPC classification number: C07D491/056 , C07D217/26 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/06 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/06 , C07D471/04 , C07D491/04 , C07D491/048 , C07F7/0812

Abstract: The present invention relates to compound (I) or a salt thereof which has a RORγt inhibitory action. wherein each symbol is as defined in the specification.

Abstract translation: 其中每个符号如说明书中所定义。

2.

发明申请
HETEROCYCLIC COMPOUND 审中-公开

公开(公告)号：US20180319812A1

公开(公告)日：2018-11-08

申请号：US16035277

申请日：2018-07-13

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Satoshi Yamamoto , Junya Shirai , Hiroyuki Watanabe , Shoji Fukumoto , Tsuneo Oda , Hidekazu Tokuhara , Yoshihide Tomata , Naoki Ishii , Michiko Tawada , Mitsunori Kono , Atsuko Ochida , Takashi Imada , Yoshiyuki Fukase , Tomoya Yukawa

IPC: C07D491/056 , C07F7/08 , C07D217/26 , C07D413/12 , C07D401/12 , C07D405/12 , C07D401/04 , C07D413/14 , C07D491/048 , C07D471/04 , C07D417/06 , C07D413/06 , C07D409/06 , C07D405/06 , C07D401/06 , C07D491/04

CPC classification number: C07D491/056 , C07D217/26 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/06 , C07D405/12 , C07D409/06 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/06 , C07D471/04 , C07D491/04 , C07D491/048 , C07F7/0812

Abstract: The present invention relates to compound (I) or a salt thereof which has a RORγt inhibitory action. wherein each symbol is as defined in the specification.

3.

发明授权
Heterocyclic compound 有权
Title translation: 杂环化合物

公开(公告)号：US09365520B2

公开(公告)日：2016-06-14

申请号：US14755439

申请日：2015-06-30

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Satoshi Yamamoto , Junya Shirai , Tsuneo Oda , Mitsunori Kono , Atsuko Ochida , Takashi Imada , Hidekazu Tokuhara , Yoshihide Tomata , Naoki Ishii , Michiko Tawada , Yoshiyuki Fukase , Tomoya Yukawa , Shoji Fukumoto

IPC: C07D471/04 , C07D215/00 , C07D491/14 , C07D217/26 , C07F7/08 , C07D491/048 , C07D491/056 , A61K31/4375 , A61K31/472 , A61K31/4741 , C07D217/14

CPC classification number: C07D217/26 , A61K31/4375 , A61K31/472 , A61K31/4741 , C07D217/14 , C07D471/04 , C07D491/048 , C07D491/056 , C07D491/14 , C07F7/0812

Abstract: The present invention provides a heterocyclic compound having a RORγt inhibitory action.The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification. or a salt thereof.

Abstract translation: 本发明提供具有RORγt抑制作用的杂环化合物。本发明涉及由式（I）表示的化合物：其中每个符号如说明书中所定义。或其盐。

4.

发明授权
Heterocyclic compound 有权

公开(公告)号：US10000488B2

公开(公告)日：2018-06-19

申请号：US15510225

申请日：2015-09-10

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Satoshi Yamamoto , Junya Shirai , Tsuneo Oda , Takashi Imada , Mitsunori Kono , Ayumu Sato , Yoshihide Tomata , Atsuko Ochida , Naoki Ishii , Yusuke Sasaki , Yoshiyuki Fukase , Tomoya Yukawa , Shoji Fukumoto

IPC: C07D471/04 , C07D401/14 , C07D413/12 , C07D405/12 , C07D405/14 , C07D413/14 , C07D239/96 , C07D409/14 , C07D403/12 , C07D401/12 , C07D417/14 , C07D417/12

CPC classification number: C07D471/04 , A61K31/517 , A61K31/5377 , A61K31/541 , A61K31/55 , A61K31/551 , A61P1/00 , A61P11/00 , C07D239/96 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/14 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14

Abstract: The problem of the present invention is to provide a compound having a superior RORγt inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like. The present invention relates to a compound represented by the formula (I): [wherein each symbol is as described in the DESCRIPTION] or a salt thereof, which has an RORγt inhibitory action, and useful as a prophylactic or therapeutic agent for psoriasis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, rheumatoid arthritis, multiple sclerosis, uveitis, asthma, ankylopoietic spondylarthritis, systemic lupus erythematosus, chronic obstructive pulmonary disease or the like.

5.

发明授权
Heterocyclic compound 有权

公开(公告)号：US09834520B2

公开(公告)日：2017-12-05

申请号：US14775514

申请日：2014-03-13

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Satoshi Yamamoto , Junya Shirai , Yoshiyuki Fukase , Ayumu Sato , Mitsunori Kouno , Yoshihide Tomata , Atsuko Ochida , Kazuko Yonemori , Tsuneo Oda , Tomoya Yukawa

IPC: A61K31/517 , C07D239/72 , C07D239/96 , C07D403/12 , C07D401/12 , C07D409/12 , C07D239/80 , C07D413/12 , C07D417/12 , C07D471/04 , C07D265/36 , C07D217/24 , C07D405/06 , C07D475/04 , C07F7/08

CPC classification number: C07D239/96 , C07D217/24 , C07D239/80 , C07D265/36 , C07D401/12 , C07D403/12 , C07D405/06 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D475/04 , C07F7/0812

Abstract: The present invention provides a heterocyclic compound having an RORγt inhibitory action.The present invention relates to a compound represented by the formula (I): wherein Ar is a the partial structure (1) to the partial structure (5), Q is a bivalent group selected from the group consisting of (Ia)-(If), and B is a ring optionally having substituent(s), or a salt thereof.

6.

发明授权
Heterocyclic compound 有权

公开(公告)号：US09630924B2

公开(公告)日：2017-04-25

申请号：US15055108

申请日：2016-02-26

Applicant: Takeda Pharmaceutical Company Limited

Inventor： Satoshi Yamamoto , Junya Shirai , Tsuneo Oda , Mitsunori Kono , Atsuko Ochida , Takashi Imada , Hidekazu Tokuhara , Yoshihide Tomata , Naoki Ishii , Michiko Tawada , Yoshiyuki Fukase , Tomoya Yukawa , Shoji Fukumoto

IPC: C07D471/04 , C07D215/00 , C07D217/26 , C07F7/08 , C07D491/048 , C07D491/056 , A61K31/4375 , A61K31/472 , A61K31/4741 , C07D217/14 , C07D491/14

CPC classification number: C07D217/26 , A61K31/4375 , A61K31/472 , A61K31/4741 , C07D217/14 , C07D471/04 , C07D491/048 , C07D491/056 , C07D491/14 , C07F7/0812

Abstract: The present invention provides a heterocyclic compound having a RORγt inhibitory action.The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification. or a salt thereof.

7.

发明申请
HETEROCYCLIC COMPOUND 有权
Title translation: 杂环化合物

公开(公告)号：US20160229814A1

公开(公告)日：2016-08-11

申请号：US14775514

申请日：2014-03-13

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Satoshi Yamamoto , Junya Shirai , Yoshiyuki Fukase , Ayumu Sato , Mitsunori Kouno , Yoshihide Tomata , Atsuko Ochida , Kazuko Yonemori , Tsuneo Oda , Takashi Imada , Tomoya Yukawa

IPC: C07D239/96 , C07D265/36 , C07F7/08 , C07D401/12 , C07D217/24 , C07D417/12 , C07D409/12 , C07D413/12 , C07D475/04 , C07D405/06 , C07D471/04 , C07D403/12

CPC classification number: C07D239/96 , C07D217/24 , C07D239/80 , C07D265/36 , C07D401/12 , C07D403/12 , C07D405/06 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D475/04 , C07F7/0812

Abstract: The present invention provides a heterocyclic compound having an RORγt inhibitory action.The present invention relates to a compound represented by the formula (I): wherein Ar is a the partial structure (1) to the partial structure (5), Q is a bivalent group selected from the group consisting of (Ia)-(If), and B is a ring optionally having substituent(s), or a salt thereof.

Abstract translation: 本发明提供具有RORγt抑制作用的杂环化合物。本发明涉及由式（I）表示的化合物：其中Ar是部分结构（5）的部分结构（1），Q是选自（Ia） - （If ），B是任选具有取代基的环或其盐。